A $1 million dedication helps glioblastoma research at Sylvester Mind Tumor Institute.
Dolphins Most cancers Problem (DCC) and StacheStrong have teamed as much as elevate funds and consciousness for mind most cancers analysis. The philanthropic partnership, which commits to contributing $1 million over 4 years to Sylvester Complete Most cancers Middle, part of the College of Miami Miller College of Drugs, was formally introduced July 17, Glioblastoma Consciousness Day.
Glioblastoma is the commonest sort of mind most cancers. The fast-growing and aggressive mind tumor impacts about 15,000 People every year and has a five-year survival fee of round 7%, which is why there may be urgency for a treatment.
DCC, the Miami Dolphins’ year-round most cancers initiative and the NFL’s largest fundraising occasion, and StacheStrong, a non-profit group dedicated to curing mind most cancers and bettering the standard of sufferers’ lives, have pledged to assist 4 one-year mind most cancers analysis tasks at Sylvester Mind Tumor Institute (SBTI), which opened earlier this yr.
Tackling a Robust Most cancers
As a part of Sylvester’s relentless pursuit of higher therapy outcomes for difficult-to-treat cancers, SBTI takes a multidisciplinary method, bringing collectively clinicians, surgeons, translational scientists and primary scientists – all specialists in mind tumor analysis and affected person care from a number of departments inside Sylvester, the area’s solely NCI-designated most cancers middle.
Co-leading the trouble is Antonio Iavarone, M.D., a world-renowned Sylvester pediatric neuro-oncologist and knowledgeable in glioblastoma.
“This distinctive partnership between DCC and StacheStrong will assist our collaborative efforts as we work to find new, customized remedies for glioblastoma sufferers,” mentioned Dr. Iavarone, deputy director of Sylvester, co-director of SBTI and professor of neurological surgical procedure and biochemistry and molecular biology on the Miller College. “Moreover, by finding out affected person tumor samples, our researchers are gaining a greater understanding of how glioblastoma tumors evolve and develop therapy resistance. Armed with this data, we are able to develop new remedies that forestall most cancers from recurring.”
StacheStrong Assist
Each step towards discovering a treatment is welcome information to StacheStrong, which has funded greater than $5 million of mind most cancers analysis and greater than 40 medical trials and analysis grants since its formation in 2018.
Brothers Colin and GJ Gerner began StacheStrong following GJ’s glioblastoma analysis in 2017. All through his 25-month journey, rising mustaches and dwelling “StacheStrong” turned the brother’s rallying cry to have a good time GJ’s tenacity and energy. Since his passing in 2019, the Gerner household and StacheStrong have remained dedicated to honoring GJ’s legacy by supporting scientists working diligently to discover a treatment for glioblastoma.
“Being ready to not solely present hope for households and sufferers recognized with glioblastoma but additionally be a catalyst for change by teaming up with Dolphins Most cancers Problem to assist the unbelievable work Sylvester scientists are doing is one thing I’m actually obsessed with,” mentioned Colin Gerner, president, CEO and co-founder of StacheStrong. “I dream of a day when somebody recognized with glioblastoma doesn’t must undergo what I noticed my brother, GJ, endure. I’m assured, by way of this partnership, higher remedies and a treatment are inside attain.”
A Successful Staff
“The StacheStrong collaboration performs a vital position in advancing the DCC’s mission and life-saving initiatives,” mentioned DCC Govt Director Javier Sanchez. “We’re proud to assist the Gerner household as they honor GJ’s glioblastoma battle by funding focused analysis efforts on the new Sylvester Mind Tumor Institute.”
This yr, DCC celebrates its 15th yr of uniting the South Florida neighborhood to problem most cancers, having raised greater than $75 million to fund life-saving most cancers analysis at Sylvester.
“The funding by way of this partnership will go a protracted approach to assist Sylvester’s mission to sort out probably the most difficult cancers, and glioblastoma is excessive on that checklist,” mentioned Stephen D. Nimer, M.D., director of Sylvester, Oscar de la Renta Endowed Chair in Most cancers Analysis and government dean for analysis on the Miller College. “Underneath the management of Dr. Iavarone, who has been a pacesetter in mind tumor analysis for greater than 20 years, these analysis grants from DCC and StacheStrong will present our physician-scientists with the assets to maneuver the needle and enhance outcomes for mind most cancers sufferers.”
Tags: DCC, Dr. Antonio Iavarone, Dr. Stephen Nimer, glioblastomas, StacheStrong, Sylvester Complete Most cancers Middle
